Michael Sarcone
Stock Analyst at Jefferies
(0.13)
# 4,488
Out of 5,113 analysts
9
Total ratings
25%
Success rate
-26.97%
Average return
Main Sectors:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Buy | $29 → $36 | $34.11 | +5.54% | 2 | Dec 4, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Hold | $160 → $85 | $82.01 | +3.65% | 1 | Oct 24, 2025 | |
| ALGN Align Technology | Downgrades: Hold | $215 → $140 | $164.92 | -15.11% | 1 | Oct 10, 2025 | |
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $4.08 | -50.98% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $30.02 | +216.46% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $123.94 | +0.86% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $7.58 | +31.93% | 1 | Mar 21, 2023 |
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $29 → $36
Current: $34.11
Upside: +5.54%
Inspire Medical Systems
Oct 24, 2025
Downgrades: Hold
Price Target: $160 → $85
Current: $82.01
Upside: +3.65%
Align Technology
Oct 10, 2025
Downgrades: Hold
Price Target: $215 → $140
Current: $164.92
Upside: -15.11%
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $4.08
Upside: -50.98%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $30.02
Upside: +216.46%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $123.94
Upside: +0.86%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $7.58
Upside: +31.93%